BAM
IMGN

Blueshift Asset Management’s Immunogen Inc IMGN Stock Holding History

Blueshift Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,616
Closed -$89K – 704
2022
Q3 		$89K Buy
+18,616
New +$98.1K 0.02% 557
2022
Q2 		– Sell
-57,393
Closed -$273K – 1065
2022
Q1 		$273K Buy
+57,393
New +$318K 0.02% 646
2021
Q4 		– Sell
-46,778
Closed -$265K – 1305
2021
Q3 		$265K Buy
46,778
+25,605
+121% +$148K 0.01% 862
2021
Q2 		$140K Sell
21,173
-5,467
-21% -$38.1K 0.01% 864
2021
Q1 		$216K Buy
+26,640
New +$218K 0.02% 751

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Blueshift Asset Management's IMGN Position: Q4 2022 in Review

Blueshift Asset Management sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 18,616 shares — an estimated $89K sold.

Blueshift Asset Management first reported a position in IMGN in Q1 2021 and held it in 5 quarters. The position peaked at $273K in Q1 2022. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Blueshift Asset Management reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 18,616 Immunogen Inc shares in Q4 2022, an estimated $89K.
  • Blueshift Asset Management first reported a position in Immunogen Inc in Q1 2021 and held it in 5 quarters.
  • Blueshift Asset Management's Immunogen Inc position peaked at $273K in Q1 2022.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Blueshift Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.